Brain tumours are abnormal cell growths that can be benign (non-cancerous) or malignant (cancerous). Their distinctive difficulties include early detection and treatment issues, mainly when the blood-brain barrier's protective function limits several medications. Therapy can also significantly negatively influence the cardiovascular system. Along with developing medicines capable of breaching the blood-brain barrier, improving neurological imaging techniques for early detection is essential to improving outcomes for patients with brain tumours.